iiinova — where your digital self keeps evolving

Gísli @ipfdoc.bsky.social · 03/05/2026

I may be biased, but what a worthy winner of this award. @kerrijohannson.bsky.social commitment to improving care & quality of life for patients with respiratory disease is second to none! She is an inspiration to the community! 👏👏👏👏 Kerri

250

Reposted by Gísli

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 17/04/2026

Dr. Veronica Marcoux presents official Canadian Thoracic Society position statement “Infection screening before starting immunosuppression in interstitial lung disease” 🫁 Addressing MTB, HIV, HBV, HCV & strongyloides @veronicasam940.bsky.social 👏 #OpenAccess www.tandfonline.com/doi/full/10....

Dr Marcoux at podium with slide in background

Summary of recommendations from the paper

295

Reposted by Gísli

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 17/04/2026

Older men with a microphone 🎤 Stop pointing out how many women are speaking at a conference. It’s not novel or noteworthy. It should be standard in 2026.

071

Reposted by Gísli

KaminskiMed @kaminskimed.bsky.social · 18/04/2026

The scientific news Antivexers in our gov do not want you to see. Maternal RSV vax protects of newborn infants‼️ Great to see a gov health agency doing its job without being harassed by charlatans, grifters, eugenicists. 👏🏼UKHSA👏🏼 #VaccinesWork www.gov.uk/government/n...

052

Reposted by Gísli

American Thoracic Society (ATS) @atscommunity.bsky.social · 18/04/2026

Check out the American Thoracic Society at #CRC2026! ❤️🇨🇦 Irina Petrache, MD, ATSF, immediate-past president of the ATS, presented on international perspectives, and along with ATS CEO Karen Collishaw, MPP, connected with leaders in health care and respiratory medicine from around the world.

132

Reposted by Gísli

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 08/04/2026

Have you ever wanted to write an official ATS clinical practice guideline or technical statement or workshop report but didn’t know where to start? Then THIS podcast is for you! 🤩 Just out from @ats-clinicalprobs.bsky.social @ats-assemblies.bsky.social youtu.be/7DIJRdQDu2o?...

youtu.be

How to Develop Your ATS Document Proposal

YouTube video by American Thoracic Society

011

Reposted by Gísli

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 08/04/2026

The most impactful clinical ILD study in ages! 🌟 True multidisciplinary collaboration driving progress 🫁 @rogerjlewis.bsky.social @ipfdoc.bsky.social A Statistical Model for Lung Function Trajectory and Mortality in Patients with Fibrotic ILD academic.oup.com/ajrccm/advan... #OpenAccess

022

Reposted by Gísli

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 16/03/2026

I thought he was playing golf?

062

Reposted by Gísli

ATSScholar @atsscholar.bsky.social · 20/01/2026

Multidisciplinary Videoconferencing for Physician Education and Remote Management of Interstitial Lung Disease @atscommunity.bsky.social #medsky 🔗 tinyurl.com/2cjt69hv

033

Gísli @ipfdoc.bsky.social · 03/03/2026

I wonder how much of my life has been wasted resetting passwords! 😫😫

010

Gísli @ipfdoc.bsky.social · 21/12/2025

Time to stop publishing conference abstracts as AI will not distinguish quality between published abstract and published original research? @atsblueeditor.bsky.social @bmj.com

021

Gísli @ipfdoc.bsky.social · 21/12/2025

Indeed as if by magic this person/group/bot posted a heartwarming story about Ivy decontaminating mold spores. Trouble is beyond a 1993 abstract this was NEVER published in JACI, therefore heartwarming but probably wrong. DO NOT trust sources that can not be independently verified. Also…

121

Gísli @ipfdoc.bsky.social · 21/12/2025

www.rollingstone.com/culture/cult... Is this the unavoidable endpoint when knowledge, ego and career converge? This is a chilling article which clearly needs the academic community to find a solution, but we need to rethink how we reward academic endeavour. #NoMorePublishOrPerish

rollingstone.com

AI Is Inventing Academic Papers That Don't Exist -- And They're Being Cited in Real Journals

Academic articles from authors using large language model are creating an ecosystem of fake research that threatens human knowledge itself.

142

Gísli @ipfdoc.bsky.social · 09/12/2025

Wow! As somebody who shares your rabies paranoia that is a pretty low bar for ruling out infectious causes of sudden death and harvesting lungs. 😳

000

Gísli @ipfdoc.bsky.social · 08/12/2025

Thank you so much for your hospitality @kaminskiMed. It was wonderful to interact with so many smart, talented and enthusiastic investigators and experience what an amazing environment you get to live and work in.

031

Gísli @ipfdoc.bsky.social · 28/11/2025

Oh no - now I gotta go 👔shopping! 😂 Maybe I’ll bring a tie?! 🤔😂

021

Gísli @ipfdoc.bsky.social · 27/11/2025

Would be lovely to get your perspective.

100

Gísli @ipfdoc.bsky.social · 25/11/2025

One of the greatest shows on TV ever. I was particularly amused by the interpretation of the carrot and stick approach. 😂

130

Gísli @ipfdoc.bsky.social · 29/10/2025

The most exciting papers of the year! Could these observers provide insights into the potential of immunotherapy in other conditions? 🤔

010

Gísli @ipfdoc.bsky.social · 15/10/2025

This is a really great thread 🧵 about an important study using mixed methodology to understand a subject that rarely gets the attention it deserves. Kudos to the team @ucalgary.bsky.social guided by the brilliant @kerrijohannson.bsky.social

020

Gísli @ipfdoc.bsky.social · 28/09/2025

Would be fascinating to do an SR+MA on AF as co-meds in trials vs IMP in trials? 🤔

000

Gísli @ipfdoc.bsky.social · 28/09/2025

For sure there is no dose response really for Pirfenidone some dose response for nintedanib but really good point!

110

Gísli @ipfdoc.bsky.social · 28/09/2025

However, another study highlighting the disappearing treatment effect! Check the placebo vs Pirfenidone groups! 😳😳 we really need better drugs to #CureIPF

221

Gísli @ipfdoc.bsky.social · 28/09/2025

TETON-2 data looking good! 96ml of FVC ‘saved’ by inhaled treprostinil at 12 months. Devil will be in detail but all very promising.

152

Gísli @ipfdoc.bsky.social · 26/09/2025

youtu.be/zTs3PDEkB2w Interesting story. 1) Brexit actually increased migration. 2) Students r source of UKs immigration‘problem’, likely due to our outstanding universities 3) Cumulative asylum seeker retention builds up 4) A ‘hostile environment’ might work but at what cost & for what impact? 😬

youtu.be

UK immigration: What the numbers really show

YouTube video by Sky News

020

Gísli @ipfdoc.bsky.social · 08/09/2025

Pogacar vs Vingegaard? Alcaraz vs Sinner? Tottenham vs Arsenal? Giants vs Dodgers? Nemesis vs motivation?

010

Gísli @ipfdoc.bsky.social · 07/09/2025

I think this is a great idea, might be tricky to operationalise. The current system is breaking if not already broken. Incentivises research fraud. Will prevent people seeing the wood because of all the dodgy trees. #LessIsMore

011

Gísli @ipfdoc.bsky.social · 04/09/2025

This makes me sad (not altogether sure why), but I would like thank #DanielLevy for his hard work over last 25 yrs. The Stadium, European Glory Nights, Great teams, superstar players! 😍 There were some lows I’m sure but I don’t remember those. #COYS

030

Gísli @ipfdoc.bsky.social · 02/09/2025

Phenomenal result! FIRST positive 52 week study of inhaled therapy in #IPF. Benefits were independent of background therapy! 🤩 Along with Nerandomilast this shows importance of cAMP/PDE4 pathways in fibrosis & opens door 4 other therapies targeting these pathways! #FutureLooksBright #CureIPF

033

Reposted by Gísli

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 02/09/2025

TETON-2 phase 2 RCT of nebulized treprostinil for IPF 🫁 Positive trial 🗞️ Change in FVC at 52 weeks difference of 95.6mL (!), and 2* endpoints like K-BILD @ipfdoc.bsky.social @kaminskimed.bsky.social @tkulkarni.bsky.social @jskim8223.bsky.social www.theglobeandmail.com/investing/ma...

174

Gísli @ipfdoc.bsky.social · 09/08/2025

There is a section on Familial Pulmonary Fibrosis, genetics & telomere length, a para on spatial transcriptomics & single cell analysis, also biomarkers. But they haven’t been used add granularity 2 classification. Whilst understandable this will eventually happen, so y rush 2 reclassify now?

000

Gísli @ipfdoc.bsky.social · 09/08/2025

Well if anybody can tell me what major paradigm shifting advance in diagnosis or pathogenesis which has substantially altered our understanding of Interstitial Lung Diseases has been included in this document I might change my mind.

100

Gísli @ipfdoc.bsky.social · 08/08/2025

I think it is as valuable and interesting as this 🤣🤣🤣

000

Gísli @ipfdoc.bsky.social · 08/08/2025

Turns out the average time from guideline to implementation is 17 years!!! (So I heard from an expert in that area!)

131

Gísli @ipfdoc.bsky.social · 08/08/2025

I think there is no clinical need to update the classification, and I just can’t wait for the next update! 🥱

111

Gísli @ipfdoc.bsky.social · 08/08/2025

Not if the primary purpose is to promote the journal and the authors! #JustSaying #JobDone

120

Gísli @ipfdoc.bsky.social · 08/08/2025

I’ve just been struck by how structurally (if not functionally) similar broccoli 🥦 is to the lungs 🫁! 😍🤣

110

Reposted by Gísli

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 23/07/2025

This isn’t about Republicans or Democrats or anything to do with politics This is about men exploiting and committing sexual violence against women and girls THIS is the issue to bring to the forefront address

051

Reposted by Gísli

Waggoner Lab @labwaggoner.bsky.social · 22/07/2025

People’s brains aged faster during the COVID pandemic — even the uninfected @nature.com www.nature.com/articles/d41... @natcomms.nature.com @alirezamnk.bsky.social @spmic-uon.bsky.social @ipfdoc.bsky.social www.nature.com/articles/s41...

174

Reposted by Gísli

Carl T. Bergstrom @carlbergstrom.com · 16/07/2025

1. Kevin Gross and I just posted a new science-of-science preprint. This one explores the looming peer review crisis. As many of you know, it's becoming significantly more difficult for journal editors to find scholars willing to serve as peer reviewers for submitted manuscripts.

arxiv.org

Will anyone review this paper? Screening, sorting, and the feedback cycles that imperil peer review

Scholarly publishing relies on peer review to identify the best science. Yet finding willing and qualified reviewers to evaluate manuscripts has become an increasingly challenging task, possibly even ...

22561221

Reposted by Gísli

Annals of the ATS @annalsats.bsky.social · 16/07/2025

Incidence, Prevalence & Mortality of ILDs in Alberta, Canada Derived, tested case definitions performed well, created a dataset of ILD. Incidence was stable, prevalence increased, mortality decreased for ILD & IPF sub-group @kerrijohannson.bsky.social @agrantorser.bsky.social tinyurl.com/5n7x5w2h

262